Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1992 1
1996 2
1998 2
1999 1
2000 2
2001 2
2002 1
2003 1
2004 1
2006 3
2007 1
2008 1
2009 2
2010 1
2011 2
2012 1
2013 1
2014 1
2015 3
2016 3
2017 1
2020 1
2021 3
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Barrett Esophagus"
Page 1
ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease.
Zerbib F, Bredenoord AJ, Fass R, Kahrilas PJ, Roman S, Savarino E, Sifrim D, Vaezi M, Yadlapati R, Gyawali CP. Zerbib F, et al. Neurogastroenterol Motil. 2021 Apr;33(4):e14075. doi: 10.1111/nmo.14075. Epub 2020 Dec 28. Neurogastroenterol Motil. 2021. PMID: 33368919 Review.
Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD) do not respond completely to proton pump inhibitor (PPI) therapy. The term "refractory GERD" has been used loosely in the literature. A distinction should be made between refractory …
Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD) do not respond completely to proton pump inhibitor …
Antireflux surgery.
Smith CD. Smith CD. Surg Clin North Am. 2008 Oct;88(5):943-58, v. doi: 10.1016/j.suc.2008.06.003. Surg Clin North Am. 2008. PMID: 18790147 Review.
Antireflux surgery (ARS) is appropriate and effective management for patients who have gastroesophageal reflux disease (GERD) refractory to medical management, who are on lifelong acid suppression, or who are experiencing side effects of the medical management. ...
Antireflux surgery (ARS) is appropriate and effective management for patients who have gastroesophageal reflux disease (GERD) refractory …
Gastroesophageal reflux disease.
Kahrilas PJ. Kahrilas PJ. JAMA. 1996 Sep 25;276(12):983-8. JAMA. 1996. PMID: 8805734 Review.
CONCLUSIONS: Although esophagitis and GERD symptoms predictably respond to antisecretory medicines, the risk of adenocarcinoma from Barrett metaplasia dictates that if heartburn is refractory to treatment, chronic (>5 years), or accompanied by dysphagia, odynopha …
CONCLUSIONS: Although esophagitis and GERD symptoms predictably respond to antisecretory medicines, the risk of adenocarcinoma from Barre …
Current treatment options for esophageal diseases.
Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G. Martínek J, et al. Ann N Y Acad Sci. 2016 Oct;1381(1):139-151. doi: 10.1111/nyas.13146. Epub 2016 Jul 8. Ann N Y Acad Sci. 2016. PMID: 27391867 Review.
Exciting new developments-pharmacologic, endoscopic, and surgical-have arisen for the treatment of many esophageal diseases. Refractory gastroesophageal reflux disease presents a therapeutic challenge, and several new options have been proposed to overcome an insufficient …
Exciting new developments-pharmacologic, endoscopic, and surgical-have arisen for the treatment of many esophageal diseases. Refractory …
Minimally invasive esophagectomy for dysplastic Barrett's esophagus.
Markar SR, Hanna G. Markar SR, et al. World J Surg. 2015 Mar;39(3):608-14. doi: 10.1007/s00268-014-2746-1. World J Surg. 2015. PMID: 25145822 Review.
Minimally invasive esophagectomy should be considered the treatment of choice in patients with dysplastic Barrett's esophagus that is refractory to endoscopic therapy or those at high risk of invasive cancer....
Minimally invasive esophagectomy should be considered the treatment of choice in patients with dysplastic Barrett's esophagus …
Management of refractory and complicated reflux esophagitis.
Hirschowitz BI. Hirschowitz BI. Yale J Biol Med. 1996 May-Jun;69(3):271-81. Yale J Biol Med. 1996. PMID: 9165696 Free PMC article. Review.
When complicated by stricture, dilatations with potent acid suppression are needed. Barrett's esophagus is subject to esophagitis, which is no more difficult to treat than other cases of esophagitis. Reflux in Barrett's esophagus should be treated on i …
When complicated by stricture, dilatations with potent acid suppression are needed. Barrett's esophagus is subject to esophagi …
Management of severe gastroesophageal reflux disease.
DiPalma JA. DiPalma JA. J Clin Gastroenterol. 2001 Jan;32(1):19-26. doi: 10.1097/00004836-200101000-00006. J Clin Gastroenterol. 2001. PMID: 11154163 Review.
Some patients with GERD experience persistent daytime or nighttime heartburn and some sustain severe damage, including ulceration, stricture, and Barrett's esophagus, which can predispose to development of adenocarcinoma. ...Proton pump inhibitors are quickly becomi …
Some patients with GERD experience persistent daytime or nighttime heartburn and some sustain severe damage, including ulceration, stricture …
Gastroesophageal reflux disease and Barrett's esophagus.
Vaira D, Gatta L, Ricci C, Castelli V, Fiorini G, Kajo E, Lanzini A. Vaira D, et al. Intern Emerg Med. 2011 Aug;6(4):299-306. doi: 10.1007/s11739-010-0427-0. Epub 2010 Jul 8. Intern Emerg Med. 2011. PMID: 20614201 Review.
The spectrum of injury includes esophagitis, stricture, the development of columnar metaplasia in place of the normal squamous epithelium (Barrett's esophagus), and adenocarcinoma. Barrett's esophagus is a premalignant lesion detected in the majority o …
The spectrum of injury includes esophagitis, stricture, the development of columnar metaplasia in place of the normal squamous epithelium ( …
Barrett's esophagus: a review.
Sjogren RW Jr, Johnson LF. Sjogren RW Jr, et al. Am J Med. 1983 Feb;74(2):313-21. doi: 10.1016/0002-9343(83)90635-6. Am J Med. 1983. PMID: 6337489 Review.
Barrett's esophagus may be defined as a columnar epithelium-lined distal esophagus. ...The treatment of Barrett's esophagus is directed toward objective cessation of gastroesophageal reflux. ...
Barrett's esophagus may be defined as a columnar epithelium-lined distal esophagus. ...The treatment of Barrett' …
Pharmacologic strategies for treating gastroesophageal reflux disease.
Vivian EM, Thompson MA. Vivian EM, et al. Clin Ther. 2000 Jun;22(6):654-72. doi: 10.1016/S0149-2918(00)90002-X. Clin Ther. 2000. PMID: 10929915 Review.
When these measures are unsuccessful, treatment with prescription-strength medications is required to prevent complications, such as Barrett's esophagus or esophageal adenocarcinoma. METHODS: Current guidelines for the management of GERD were identified through a ME …
When these measures are unsuccessful, treatment with prescription-strength medications is required to prevent complications, such as Barr …
40 results